Debate Series - Estro-events.org
Debate Series - Estro-events.org
Debate Series - Estro-events.org
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
sCiEnTiFiC proGrAMME<br />
Sunday 13 May 2012<br />
CliniCal inTERdiSCiPlinaRy PhySiCS RadiObiOlOgy RTT yOung<br />
Page 182 PROgRammE & ExhibiTiOn guidE • ESTRO 31<br />
abS. numbER<br />
SYMPOSIUM<br />
how dEEp doEs hpV ChAnGE h&n TrEATMEnT sTrATEGy?<br />
lEaRning ObJECTivES:<br />
1. To describe and discuss the epidemiology and clinical features of HPV induced head<br />
and neck cancer<br />
2. To describe the biology, detection methods and targeting of HPV<br />
3. To discuss the role of HPV status for prognosis and choice of treatment<br />
09:15 - 10:30 • Room 115<br />
ChaiR: C. Grau (Denmark)<br />
CO-ChaiR: S. Rivera (France)<br />
09:15 > Epidemiology and clinical features<br />
SPEaKER: P. Lassen (Denmark) SP-0586<br />
09:40 > Biology and targeting of HPV<br />
SPEaKER: L. Licitra (Italy) SP-0587<br />
10:05 > HPV positive vs. HPV negative oropharyngeal carcinoma:<br />
deescalating vs. intensified treatment<br />
SPEaKER: B. O’Sullivan (Canada) SP-0588<br />
SYMPOSIUM<br />
AdVAnCEs in dosE CAlCUlATion And opTiMisATion AlGoriThMs. iMpro-<br />
VinG plAnninG EFFiCACiTy And plAn QUAliTy<br />
09:15 - 10:30 • Room 117<br />
ChaiR: T. Knöös (Sweden)<br />
CO-ChaiR: M. Duch (Spain)<br />
09:15 > MCO for IMRT planning<br />
SPEaKER: D. Craft (USA) SP-0589<br />
09:33 > Multi-criteria optimization in radiation oncology:<br />
from priorisation to interaction<br />
SPEaKER: A. Schlaefer (Germany) SP-0590<br />
09:51 > Introduction to grid-based solvers of Boltzmann transport equation<br />
SPEaKER: O. Vassiliev (Canada) SP-0591<br />
Sunday 13 May 2012<br />
10:09 > Fast and accurate solution of the Boltzmann radiation transport<br />
equation for RT: implementation and validation<br />
SPEaKER: K. Bush (USA) SP-0592<br />
SYMPOSIUM<br />
nAnopArTiClEs in rT<br />
lEaRning ObJECTivES:<br />
1. Description and overview of nanotechnology and potential applications<br />
2. Understanding the clinical perspective on radiosensitisers<br />
3. Explanation of nanoparticle mediated radiation dose enhancement<br />
4. Identification of future potential areas of research and clinical trials<br />
abS. numbER<br />
09:15 - 10:30 • Room 116<br />
ChaiR: B. McClean (Ireland Republic of)<br />
CO-ChaiR: J. Vilar Palop (Spain)<br />
09:15 > Green nanotechnology generates gold nanoparticles (AuNP-EGCG):<br />
implications in prostate tumor therapy<br />
SPEaKER: K. Katti (USA) SP-0593<br />
09:33 > Physical perspective on radiation response modulation of<br />
tumors using gold nanoparticles<br />
SPEaKER: S.H. Cho (USA) SP-0594<br />
09:51 > Gold nanoparticles as radiosensitisers<br />
SPEaKER: S. Jain (Canada) SP-0595<br />
10:09 > Toronto experience in gold nanoparticles radiosensitization<br />
SPEaKER: J. Pignol (Canada) SP-0596<br />
ESTRO 31 • PROgRammE & ExhibiTiOn guidE Page 183<br />
sCiEnTiFiC proGrAMME<br />
eSTRO 31
Change language